Our Mission

Axonis Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.

Executive Team

JOANNA STANICKA, Ph.D.

Chief Executive Officer, President & Co-Founder

SHANE V. HEGARTY, Ph.D.

Chief Scientific Officer & Co-Founder

DONALD C. MANNING, MD, Ph.D.

Chief Medical Officer

JEFF IMBARO, M.B.A.

Chief Operating Officer

Scroll to Top